Sponsors (8)
The bill reduces ambiguity and strengthens Medicare program‑integrity enforcement by defining abortion‑related terms and restricting prescribing, but it does so in ways that narrow access to medication abortion (especially via telehealth and nonphysician providers), raise costs and delays for patients, and impose permanent penalties with limited appeal for providers.
Medicare beneficiaries and taxpayers gain stronger program‑integrity protections because the bill allows exclusion of providers who prescribe abortion‑inducing drugs outside the statute, reducing improper claims and clarifying enforcement authority.
Federal administrators and providers get clearer legal guidance because the bill adds explicit statutory definitions for 'abortion‑inducing drug' and 'unborn child', reducing ambiguity for enforcement, claims processing, and compliance.
Medicare beneficiaries who seek medication abortion (or related care) are likely to face reduced access because providers who prescribe under broader standards can be excluded, directly limiting available treatment options.
Telemedicine access for medication abortion and related services will be curtailed — remote prescribing or administration is banned unless a physician is physically present — reducing convenient care options for rural, homebound, and travel‑limited patients.
Nonphysician clinicians (nurse practitioners, physician assistants, telehealth clinicians) could be barred from providing medication abortion, shrinking the provider workforce and worsening access especially in underserved areas.
Based on analysis of 2 sections of legislative text.
Adds a permanent federal exclusion for providers/entities that prescribe, administer, dispense, or furnish abortion‑inducing drugs unless a physician examines the patient in person, is present for administration/use, and schedules a 14‑day in‑person follow‑up.
Introduced February 13, 2025 by W. Greg Steube · Last progress February 13, 2025
Creates a new permanent federal exclusion from participation in federal healthcare programs for any person or entity that, on or after enactment, prescribes, administers, dispenses, or furnishes an abortion‑inducing drug unless four strict conditions are met: a physician performs an in‑person physical exam, the prescriber is a physician, the physician is physically present in the same room when the patient takes/uses/is administered the drug, and an in‑person follow‑up visit is scheduled within 14 days. The bill defines “abortion‑inducing drug” broadly (including off‑label uses) and adopts the term “unborn child” by reference to federal law; it makes these exclusions permanent and removes certain statutory protections that otherwise apply to exclusions under the referenced Social Security Act provision.